Skip to main content
. 2022 Nov 10;13:1045206. doi: 10.3389/fmicb.2022.1045206

Table 2.

Overview of the recommendations for antimicrobial treatment of CRAB infections in Arab countries in the Middle East, Italy, and China.

Arab countries of the Middle East Italy China
Bacteraemia and nosocomial pneumonia:
stable patients:
  • Colistina or polymyxin B monotherapy

critically ill patients:
  • Colistina or polymyxin B in combination with one of the following:

  • Aminoglycosideb

  • Ampicillin/sulbactam

  • Carbapenem (high-dose, extended infusion)

  • Fosfomycin

  • Minocycline

  • Rifampicin

  • Tigecycline (high-dose)

cUTI and cSSTI
Monotherapy with one of the following:
  • Aminoglycoside

  • Ampicillin/sulbactam

  • Carbapenem (high-dose, extended infusion)

  • Colistin

  • Doxycyclinec

  • Fosfomycind

  • Tigecyclinec

  • Trimethoprim-sulfamethoxazole

  • Strongly recommend a consultation by specialists;

  • Rigorous monitoring of renal function is strongly recommend when colistin is administered;

  • Further studies are necessary to estimate the use of cefiderocol.

First choice according to drug sensitivity results:
  • Compound preparation containing sulbactam

  • Aminoglycoside

  • Fluoroquinolone

  • Minocycline

  • SMZ-TMP

Secondary choice according to drug sensitivity results:
  • Tigecycline

  • Polymyxin

  • Other β Lactamase inhibitor compound preparations

cUTI, complicated urinary tract infection; cSSTI, complicated skin and soft tissue infection; SMZ-TMP, sulfamethoxazole-trimethoprim. a intravenous and inhaled (nebulized) for patients with pneumonia. b for bacteraemia only. c for cSSTI only. d for cUTI only.